BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 2817839)

  • 1. Microtubular reorganization and dendritic growth response in Alzheimer's disease.
    McKee AC; Kowall NW; Kosik KS
    Ann Neurol; 1989 Nov; 26(5):652-9. PubMed ID: 2817839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tau regulates Arc stability in neuronal dendrites via a proteasome-sensitive but ubiquitin-independent pathway.
    Yakout DW; Shroff A; Wei W; Thaker V; Allen ZD; Sajish M; Nazarko TY; Mabb AM
    J Biol Chem; 2024 May; 300(5):107237. PubMed ID: 38552740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Collapsin Response Mediator Proteins: Novel Targets for Alzheimer's Disease.
    Quach TT; Moutal A; Khanna R; Deems NP; Duchemin AM; Barrientos RM
    J Alzheimers Dis; 2020; 77(3):949-960. PubMed ID: 32804096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How do neurons age? A focused review on the aging of the microtubular cytoskeleton.
    Richardson B; Goedert T; Quraishe S; Deinhardt K; Mudher A
    Neural Regen Res; 2024 Sep; 19(9):1899-1907. PubMed ID: 38227514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mass spectrometry-based proteomics in neurodegenerative lysosomal storage disorders.
    Li W; Cologna SM
    Mol Omics; 2022 May; 18(4):256-278. PubMed ID: 35343995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Putative dendritic correlates of chronic traumatic encephalopathy: A preliminary quantitative Golgi exploration.
    Warling A; Uchida R; Shin H; Dodelson C; Garcia ME; Shea-Shumsky NB; Svirsky S; Pothast M; Kelley H; Schumann CM; Brzezinski C; Bauman MD; Alexander A; McKee AC; Stein TD; Schall M; Jacobs B
    J Comp Neurol; 2021 May; 529(7):1308-1326. PubMed ID: 32869318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Capzb2 PROTEIN EXPRESSION IN THE BRAINS OF PATIENTS DIAGNOSED WITH ALZHEIMER'S DISEASE AND HUNTINGTON'S DISEASE.
    Vanderburg CR; Davis DA; Diamond RE; Kao PF; Delalle I
    Transl Neurosci; 2010 Mar; 1(1):55-58. PubMed ID: 29662700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tau-mediated synaptic damage in Alzheimer's disease.
    Jadhav S; Cubinkova V; Zimova I; Brezovakova V; Madari A; Cigankova V; Zilka N
    Transl Neurosci; 2015; 6(1):214-226. PubMed ID: 28123806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tangles, Toxicity, and Tau Secretion in AD - New Approaches to a Vexing Problem.
    Gendreau KL; Hall GF
    Front Neurol; 2013 Oct; 4():160. PubMed ID: 24151487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The intersection of amyloid β and tau in glutamatergic synaptic dysfunction and collapse in Alzheimer's disease.
    Crimins JL; Pooler A; Polydoro M; Luebke JI; Spires-Jones TL
    Ageing Res Rev; 2013 Jun; 12(3):757-63. PubMed ID: 23528367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electrophysiological changes precede morphological changes to frontal cortical pyramidal neurons in the rTg4510 mouse model of progressive tauopathy.
    Crimins JL; Rocher AB; Luebke JI
    Acta Neuropathol; 2012 Dec; 124(6):777-95. PubMed ID: 22976049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased expression of TrkB and Capzb2 accompanies preserved cognitive status in early Alzheimer disease pathology.
    Kao PF; Banigan MG; Vanderburg CR; McKee AC; Polgar PR; Seshadri S; Delalle I
    J Neuropathol Exp Neurol; 2012 Jul; 71(7):654-64. PubMed ID: 22710966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accumulation of vesicle-associated human tau in distal dendrites drives degeneration and tau secretion in an in situ cellular tauopathy model.
    Lee S; Kim W; Li Z; Hall GF
    Int J Alzheimers Dis; 2012; 2012():172837. PubMed ID: 22315694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulators of cytoskeletal reorganization in CA1 hippocampal neurons show increased expression in patients at mid-stage Alzheimer's disease.
    Kao PF; Davis DA; Banigan MG; Vanderburg CR; Seshadri S; Delalle I
    PLoS One; 2010 Oct; 5(10):e13337. PubMed ID: 20967212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of WAVE accumulation in Abeta/APP pathology-dependent tangle modification in Alzheimer's disease.
    Takata K; Kitamura Y; Nakata Y; Matsuoka Y; Tomimoto H; Taniguchi T; Shimohama S
    Am J Pathol; 2009 Jul; 175(1):17-24. PubMed ID: 19497998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Small-molecule mediated neuroprotection in an in situ model of tauopathy.
    Honson NS; Jensen JR; Abraha A; Hall GF; Kuret J
    Neurotox Res; 2009 Apr; 15(3):274-83. PubMed ID: 19384600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ibuprofen reduces Abeta, hyperphosphorylated tau and memory deficits in Alzheimer mice.
    McKee AC; Carreras I; Hossain L; Ryu H; Klein WL; Oddo S; LaFerla FM; Jenkins BG; Kowall NW; Dedeoglu A
    Brain Res; 2008 May; 1207():225-36. PubMed ID: 18374906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tau aggregation and progressive neuronal degeneration in the absence of changes in spine density and morphology after targeted expression of Alzheimer's disease-relevant tau constructs in organotypic hippocampal slices.
    Shahani N; Subramaniam S; Wolf T; Tackenberg C; Brandt R
    J Neurosci; 2006 May; 26(22):6103-14. PubMed ID: 16738255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ApoE-dependent plasticity in Alzheimer's disease.
    Teter B
    J Mol Neurosci; 2004; 23(3):167-79. PubMed ID: 15181245
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.